Please see below for information on the U.S. Food and Drug Administration’s Broad Agency Announcement (BAA). One Health is a BAA category listed among the topics of priorities to support regulatory science and innovation at FDA. Fiscal Year 2023 was the first year One Health was included in FDA’s BAA Day. Detailed information related to all BAA priority topics (including One Health) can be found here. A detailed overview of the BAA notice can be found here. A summary of the One Health BAA presentation given during BAA Day can be found here. There is a scheduled 3-hour BAA Question and Answer Session that will take place for potential applicants on January 16th, 2024, 1-4 pm EST. This is a public event for potential fiscal year 2024 applicants. FDA’s Office of Acquisitions and Grants Services (OAGS) and Office of Regulatory Science and Innovation (ORSI) will present at the event. Feel free to advertise this session to potential applicants. FY24 FDA Broad Agency Announcement Question and Answer Session - 01/16/2024 | FDA. Event handles for Linkedin and twitter:


Any fiscal year 2024 BAA solicitation amendments can be made via BAA Amendment Request Form - PowerApps for posting on 1/12/24 (last date to post amendments to the FY24 BAA solicitation).

Provided by:

Brianna Skinner, DVM, MPH, DACLAM, CAPT, USPHS, Senior Regulatory Veterinarian, Office of Counterterrorism and Emerging Threats, Office of the Chief Scientist, (240) 402-1240 (office), (240) 517-2552 (iphone)